The EMBO Journal
 
Advanced search
Journal home
Aims and scope
Current issue
Advance Online Publication
Web Focuses
Archive:-
Browse by issue
Browse by subject
Browse by category
Free online sample issue
Press releases
Authors & Referees
Editorial process
Guide for authors
Submit an article
Guide for referees
Editorial Team, Senior Advisors and Advisory Editorial Board
Contact Editorial office
Customer services
Subscribe
Order sample copy
Purchase articles
Reprints and permissions
Contact NPG
Advertising
EMBO
www.embo.org
Article
The EMBO Journal (2001) 20, 3760–3770, doi:10.1093/emboj/20.14.3760
Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology
Dimitris Kontoyiannis1, Alexey Kotlyarov2, Ester Carballo3, Lena Alexopoulou1, 4, Perry J. Blackshear3, Matthias Gaestel2, Roger Davis5, Richard Flavell4 and George Kollias1
1 Institute of Immunology, BSRC 'Alexander Fleming', 166 72 Vari, Greece
2 Innovationskolleg Zellspezialisierung, Martin-Luther-Universität Halle Wittenberg, D-06120 Halle, Germany
3 Laboratory of Signal Transduction, NIEHS, National Institutes of Health, Research Triangle Park, NC 27709, USA
4 Section of Immunobiology and Howard Hughes Medical Institute, Yale University School of Medicine, 310 Cedar Street, New Haven, CT 06520-8011, USA
5 Howard Hughes Medical Institute, Program in Molecular Medicine, Department of Biochemistry and Molecular Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA

To whom correspondence should be addressed
George Kollias, giorgos_kollias@hol.gr

Received 20 December 2000; Revised 3 May 2001; Accepted 29 May 2001.
Abstract
Interleukin-10 (IL-10) is a key inhibitory signal of inflammatory responses that regulates the production of potentially pathogenic cytokines like tumor necrosis factor (TNF). We show here that the development of chronic intestinal inflammation in IL-10-deficient mice requires the function of TNF, indicating that the IL-10/TNF axis regulates mucosal immunity. We further show that IL-10 targets the 3' AU-rich elements (ARE) of TNF mRNA to inhibit its translation. Moreover, IL-10 does not alter TNF mRNA stability, and its action does not require the presence of the stability-regulating ARE binding factor tristetraprolin, indicating a differential assembly of stability and translation determinants on the TNF ARE. Inhibition of TNF translation by IL-10 is exerted mainly by inhibition of the activating p38/MAPK-activated protein kinase-2 pathway. These results demonstrate a physiologically significant cross-talk between the IL-10 receptor and the stress-activated protein kinase modules targeting TNF mRNA translation. This cross-talk is necessary for optimal TNF production and for the maintenance of immune homeostasis in the gut.
Keywords: animal model, anti-inflammatory, Crohn's disease, gene expression, knockout
Send to a friendEmail link to a friend
PDFDownload PDF
Full textFull text
Next article
Previous article
Table of contents
rights and permissionsRights and permissions
order commercial reprintsReprints
ToC alertRegister for table of contents by email
  Privacy policy Copyright © 2001 by the European Molecular Biology Organization